Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia

softbones October 28, 2020

0 Comments

To read more please click on the link below.
Read Article

Categories: Scientific Publications

Tags: anti-sclerostin monoclonal antibody, BPS804 in adult hypophosphatasia

Patient of the Month- Amedie P.

If you would like to donate to Soft Bones in honor of Amedie, please click the button below! Donate Here Hi!! My name is Amedie.…

Margaret Robb April 1, 2025

0 Comments

Patient of the Month- Alison S.

If you would like to donate to Soft Bones in honor of Alison, please click the button below! Donate Here Hi, I’m Alison, and I’m…

Margaret Robb May 1, 2025

0 Comments

Impact of muscular symptoms and/or pain on disease characteristics, disability, and quality of life in adult patients with hypophosphatasia: A cross-sectional analysis from the Global HPP Registry

To read more please click on the link below. Read Article

Margaret Robb November 22, 2023

0 Comments

Patient of the Month- Judith H.

If you would like to make a donation to Soft Bones in honor of Judith, please click the button below! Donate Here I started life…

Denise Goodbar October 31, 2023

0 Comments

Mineral Intake and Clinical Symptoms in Adult Patients with Hypophosphatasia

To read more please click on the link below.Read Article

Denise Goodbar August 7, 2023

0 Comments

Responses

You must be logged in to post a comment.

Mail Address (P.O Box)
The US Hypophosphatasia Foundation
141 Hawkins Place, #267
Boonton, NJ 07005, USA.

Organization

Programs

Community

Office Address (Location for meetings and events)
1719 NJ-10, Suite 315
Parsippany, NJ 07054

Follow Us on Social Media!

Disclaimer: This Website is owned by Soft Bones, Inc. All materials contained in this Website (the “Materials”) are either owned by or licensed to us and are protected by intellectual property and other laws. We retain all proprietary rights to the Materials. This Website is copyrighted. All rights are reserved. Except as expressly authorized by us, any use, copy, reproduction, display, performance, modification or retransmission of the Materials is strictly prohibited.

Related Articles

Responses